| Title |
Subconjunctival dexamethasone implant for non-necrotizing scleritis
|
|---|---|
| Published in |
Journal of Ophthalmic Inflammation and Infection, January 2013
|
| DOI | 10.1186/1869-5760-3-7 |
| Pubmed ID | |
| Authors |
Heloisa Nascimento, Maíra França, Luciana Guadalupe García, Cristina Muccioli, Rubens Belfort |
| Abstract |
The purpose of this study is to report the management of non-necrotizing anterior scleritis with a single-dose subconjunctival 0.7 mg dexamethasone implant (Ozurdex®, Allergan, Inc., CA, USA). Six patients with clinical diagnosis of non-necrotizing anterior scleritis (diffuse, sectorial, and nodular) were submitted to subconjunctival injection of dexamethasone implant. The injection was performed under topical anesthesia at the slit lamp. All patients reported only mild discomfort related to the procedure. Five patients had subconjunctival hemorrhage. Follow-up was performed 1, 7, 15, 30, and 45 days, and 2, 3, 4, 5, and 6 months after the procedure. Visual acuity, intraocular pressure, anterior and posterior biomicroscopy, and fundus exams were performed in each visit. |
Mendeley readers
The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Peru | 1 | 5% |
| Unknown | 19 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 4 | 20% |
| Professor > Associate Professor | 3 | 15% |
| Other | 2 | 10% |
| Researcher | 2 | 10% |
| Student > Bachelor | 1 | 5% |
| Other | 4 | 20% |
| Unknown | 4 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 13 | 65% |
| Biochemistry, Genetics and Molecular Biology | 1 | 5% |
| Social Sciences | 1 | 5% |
| Computer Science | 1 | 5% |
| Unknown | 4 | 20% |